GSK 429286

Cat No. 3726

GSK 429286 C21H16F4N4O2

Price and Availability

For GSK 429286 pricing & availability please select your country from the drop down menu:
Submit

Chemical Name: 4-[4-(Trifluoromethyl)phenyl]-N-(6-Fluoro-1H-indazol-5- yl)-2-methyl-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxa mide

Biological Activity

Selective Rho-kinase inhibitor (IC50 values are 14, 780 and 1940 nM for ROCK1, RSK and p70S6K respectively). Reverses adrenalin-induced contraction of the rat aortic ring (IC50 = 190 nM) and causes a dose-dependent decrease in mean arterial blood pressure in spontaneous hypertensive rats. Orally active.

Licensing Information

Sold for research purposes under agreement from GlaxoSmithKline.

Technical Data

M.Wt:
432.37
Formula:
C21H16F4N4O2
Solubility:
Soluble to 100 mM in DMSO and to 50 mM in ethanol
Purity:
>97 %
Storage:
Store at +4°C

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis and MSDS.

Certificate of Analysis / MSDS

Certificate of Analysis: View current batch
Material Safety Data Sheet: View current batch

References

Goodman et al (2007) Development of dihydropyridone indazole amides as selective rho-kinase inhibitors. J.Med.Chem. 50 6. Nichols et al (2009) Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's disease. Biochem.J. 424 47.

If you know of a useful citation for this product please let us know.

Keywords: GSK 429286, Selective, Rho-kinases, ROCK, inhibitors, Rho-Associated, Coiled-Coil, Kinases, p160ROCK, ROK, GSK429286, GlaxoSmithKline

Buy Now / Print Quote

Find multiple products by catalog number


divider line

Print Quote Facility

Order via your purchasing department

Print Quote Facility

It's now even easier to place orders via your purchasing department.

Simply add a product to your cart & click on the "Print Quote" button.

more
divider line

Cancer Research Guide

Cancer Research Guide

Highlights over 400 products for cancer research. Request a copy or view PDF today.

request
divider line

Kinase Research Guide

Kinase Research Guide

Highlights over 220 products for kinase research. Request a copy or view PDF today.

request
divider line

Kinase Inhibitor Toolbox

80 Kinase inhibitors
pre-dissolved in DMSO

Some of the most potent
kinase inhibitors all on one plate

Includes many of the latest kinase inhibitors to become commercially available. Covers a wide range of kinase targets including EGFR, MAPK and CDK.

more
divider line

Calcium Imbalance and Neuroprotective Targets

Written by E. Besancon et al

Neuroprotection Poster

'Calcium Imbalance and Neuro-protective Targets in Cerebral Ischemia & Brain Injury' highlights the key targets involved in stroke, trauma and neurodegeneration.

request
divider line

VEGF Pathway & Anti-Angiogenic Therapy

Written by N. Ferrara & Y. Crawford

Angiogenesis Poster

A summary of antiangiogenic therapies targeting the VEGF pathway and the mechanisms of therapy resistance.

request
divider line

New Products in this Area

kb NB 142-70

Selective PKD inhibitor; analog of CID744673 (Cat.No. 3327).

3-Methyladenine

Class III PI 3-kinase inhibitor; also inhibits autophagy

FR 236924

Selective PKCε activator

AR-A 014418

Selective GSK-3 inhibitor

MeBIO

Inactive analog of BIO (Cat. No. 3194)

DMAT

Cell-permeable inhibitor of CK2; also inhibits Pim kinase and PKD1

Y 39983 dihydrochloride

Selective Rho-kinase (ROCK) inhibitor

TWS 119

GSK-3β inhibitor; induces neuronal differentiation in ESCs

SR 3677 hydrochloride

Potent, selective Rho-kinase (ROCK) inhibitor

PD 166285 dihydrochloride

Potent Src inhibitor; also inhibits FGFR1, PDGFRβ and Wee1

BIO-acetoxime

Selective GSK-3α/β inhibitor

AS 605240

Potent and selective PI 3-kinase γ (PI3Kγ) inhibitor

BAG 956

Dual PI 3-kinase and PDK1 inhibitor

Sign-up for new product e-alerts
divider line

New Product Guide

New Product Guide Spring 2010

Highlights over 250 new products added in 2009/10. Request a copy or view PDF today.

request